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Abstract
The endurance shuttle walk test (ESWT) is frequently used as an outcome measure for pulmonary
rehabilitation (PR). The minimal important difference (MID) for the ESWT after a course of rehabilitation
has not been conclusively confirmed in the literature. The aim was to establish the MID for the ESWT following
the 6-week PR programme in patients with chronic obstructive pulmonary disease (COPD). Following the
completion of the 6-week PR programme, data from 531 participants were included in the analysis to estimate
the MID for the ESWT using both anchor-based and distribution-based methods. Mean age (standard deviation
(SD)) was 69.4 (9.1) years, 303 male, FEV1/FVC 0.51 (0.16). The baseline incremental shuttle walk test (ISWT)
was 217.7 (SD 139.8) metres and ESWT 195.8 (SD 118.8) seconds, which increased to 279.6 (SD 149.5) metres
and 537.4 (SD 378.3) seconds, respectively, following PR. The mean change was 61.8 (95% confidence interval
(CI) 56.0–67.5) metres for the ISWT and 342.0 (95% CI 312.4–371.6) seconds for the ESWT. The distribution
method (0.5 SD) yielded an MID of 173.7 seconds, the global rating of change scale method yielded a value of
279.2 (95% CI 244.9–313.5) seconds for those rating themselves as ‘slightly improved’ and the ROC method
207 seconds. There was no agreement between the approaches employed. However, we propose that the
MID for the ESWT in COPD following a 6-week PR programme is between 174 and 279 seconds.
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Introduction
Exercise tolerance is a commonly used outcome mea-
sure for evaluating treatment interventions in individ-
uals with chronic obstructive pulmonary disease
(COPD) in both clinical practice and research. It can
be assessed through standard cardiopulmonary exer-
cise testing (CPET, in laboratory setting)1 or using
field walking tests such as the incremental shuttle
walk test (ISWT), endurance shuttle walk test
(ESWT) or six-minute walk test (6MWT).2 These
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tests elicit different physiological responses3,4 and,
consequently, when compared, may be more or less
responsive following an intervention.
The extent of change post-intervention, while
being statistically significant, may not be meaningful
for the patient, and therefore a concept for determin-
ing the responsiveness and minimal clinically impor-
tant difference (MCID) for patient-reported outcomes
has been derived. MCID was first defined by Jaeschke
et al.5 as ‘the smallest difference in score in the
domain of interest which patients perceive as benefi-
cial and which would mandate a change in the
patient’s management’. Commonly, this approach
requires patients to report their perceived change
using a global rating of change scale. Further, a con-
cept of minimal important difference (MID) has been
established which is defined as ‘the smallest differ-
ence in score in the outcome of interest that informed
patients or informed proxies perceive as important
and which would lead the patient or clinician to con-
sider a change in the management’.6 The MID is usu-
ally derived from anchor-based methods, which use
an external criterion as an anchor which already has
an established MID. Another alternative for deriving
the MID are distribution-based methodologies that
use variability calculations like standard error of mea-
surement, standard deviation (SD) or effect size7,8
The MIDs and MCIDs for exercise tests such as
6MWT, ISWT and standard cycle CPET have been
previously studied in individuals with COPD.3,9–14
However, in pulmonary rehabilitation (PR) pro-
grammes, treatment is based around aerobic training
at a prescribed intensity, for a prolonged period of
time; and using a constant work rate test (CWR),
might be more responsive to any change elicited by
the treatment intervention.10 The most frequently
reported CWR walking test is the ESWT; however,
there are limited data describing the MID for the
ESWT derived from rehabilitation programmes. To
our knowledge, only two studies managed to estimate
a MID for the ESWT in PR. The first of these studies
reported a value using a distribution-based estimate
(186 seconds, n ¼ 132 participants) following a
7-week PR programme.15 A second study estimated
the MID using both anchor- and distribution-based
methods of analysis (2 values 186–199 seconds,
n ¼ 55 participants); however, this study was con-
ducted on a limited and specific population of indi-
viduals (COPD with chronic respiratory failure), who
attended a 12-week PR programme.16
The aim of our study was to establish an MID for
the ESWT following the completion of a shorter (6-
week) PR programme in individuals with COPD with
a broad range of disease severity using both anchor-
based and distribution-based methodologies.
Methods
Design, setting and participants
This was an evaluation of the PR programme in indi-
viduals with a confirmed diagnosis of COPD who
completed the 6-week course at the University Hos-
pitals of Leicester NHS Trust. Participants were
referred to outpatient PR either during the stable
phase of the disease or within 4 weeks of an exacer-
bation. Analysis included individuals who completed
the 6-week PR programme over a time period of 5
years (2013–2017). All participants routinely con-
firmed to data being collected within the service.
Outcome measures
The ISWT and ESWT were used to assess exercise
tolerance and for prescribing the walking training.
During the initial assessment, two ISWTs17 and one
ESWT18 were performed to recommended guide-
lines.2 The ESWT was prescribed at 85% of the pre-
dicted peak oxygen consumption (VO2Peak) estimated
from the ISWT.19 Health-related quality of life was
recorded with the use of self-reported Chronic
Respiratory Questionnaire (CRQ-SR).20
Calculating the MID
Global rating of change scale. After completing the
ESWT at the end of the programme, participants were
asked to rate how they found their exercise tolerance
using the following question: ‘Compared to your
endurance walk test before your rehabilitation pro-
gramme, how would you rate your exercise tolerance
now?’ Answers were categorized on a 7-point Likert-
type scale as (3) ‘large deterioration’, (2) ‘moder-
ate deterioration’, (1) ‘slight deterioration’, (0) ‘no
change’, (1) ‘slight improvement’, (2) ‘moderate
improvement’ and (3) ‘large improvement’.
Anchor-based methods. We used multiple anchors with
known MIDs that were acceptably correlated with the
ESWT time change (r  0.3, p < 0.05). The used
anchors were ISWT MCID of 48 metres14 and
CRQ-SR with the MID of 0.5 points for each
domain.5 For the ISWT anchor, participants were
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considered as responders if they had walked a dis-
tance greater or equal to 50 metres and non-
responders if this was shorter than 50 metres. For the
CRQ-SR anchor, participants were considered as
responders if the reported change in breathlessness
was greater or equal to 0.5 points and as non-
responders if the change was smaller than 0.5.
Distribution-based methods. As one of the distribution-
based approaches, we used calculation of half of the
standard deviation (0.5  SD) of the change, as it had
been previously used in other studies.15,16,21 As the
other approach, we performed Receiver Operating
Characteristic analyses (ROC analyses) for ESWT
change coupled with anchor variable of a reasonable
correlation (r  0.3, p < 0.05) to determine the MID
for ESWT change only using ROC describing mean-
ingful relationship [area under curve (AUC) > 0.7].8
Intervention
Participants attended an outpatient PR programme for
6 weeks as per international guidelines22,23 and
adhered to British Thoracic Society guidelines
throughout the duration of the study. Sessions were
supervised twice weekly and consisted of a warm up,
individually prescribed walking training at 85% of
predicted VO2peak derived from the best of two
ISWTs, cycling exercise and two upper and two lower
limb strength exercises with dumbbells (3 sets of 10
repetitions). Participants were also asked to perform
unsupervised walking exercises on a daily basis at
home using their prescribed walking speed and one
additional session of strength exercises; and to
record all exercise in a training diary. Participants
were encouraged to gradually progress all exercises
whenever possible based on the self-reported Borg
dyspnoea scale (0–10)24 and perceived exertion
scale (6–20)25; however, this was guided by the phy-
siotherapists in the supervised sessions.
Statistical analysis
Data were analysed using SPSS (version 20, IBM UK
Ltd, Hampshire, UK). Baseline variables were nor-
mally distributed. Parametric and non-parametric sta-
tistics were used and data reported as mean, standard
deviation and 95% confidence intervals (CIs), where
appropriate. Relationships between various anchors
and outcome measures were analysed using the
Spearman’s correlation coefficient (r). ROC analyses
was only performed on variables with meaningful
relationship (r 0.3, p < 0.05) presenting with accep-
table probability (AUC > 0.7). The power calculation
was based on the change in ESWT of 184.5 seconds
(SD 247.4) from a previous study26 in a balanced one-
way analysis of variance. For a medium effect size of
0.527 and assuming equal group sizes in the first 4
global rating of change categories (no change, slight,
moderate and large improvement), 57 participants
would be needed per category (90% power, 5% sig-
nificance). Cohen’s k was used for analysing the
agreement between methods (k > 0.2, p < 0.05). Sta-
tistical significance was set as p < 0.05.
Results
Study population
Data from 531 participants (303 male) who completed
the 6-week PR programme were analysed. The mean
(SD) age of participants at baseline was 69.4 years
(9.1) and BMI 27.9 (7.1). The participant characteris-
tics are shown in Table 1.
Participants’ response to pulmonary rehabilitation
The mean (SD) baseline ISWT for all participants was
217.7 (139.8) metres, which increased to 279.6
(149.5) metres (p < 0.001) post-rehabilitation,
exceeding the MCID for ISWT14 with a 61.9 (67.1)
metres improvement. Participants improved in the
ESWT from 195.8 (118.8) seconds at baseline to
Table 1. Baseline characteristics of participants.
Characteristic Mean (SD) unless stated otherwise
Age (years) 69.4 (9.1)
Gender
Male (%) 303 (57)
Female (%) 228 (43)
BMI (kg m2) 27.9 (7.1)
FEV1 (l) 1.29 (0.58)
FVC (l) 2.54 (0.86)
FEV1/FVC (%) 51.2 (16.4)
MRC 3.29 (1.0)
MRC 1 (%) 6 (1.1)
MRC 2 (%) 110 (20.7)
MRC 3 (%) 195 (36.7)
MRC 4 (%) 163 (30.7)
MRC 5 (%) 57 (10.7)
ISWT (m) 217.7 (139.8)
ESWT (s) 195.8 (118.8)
BMI: body mass index; SD: standard deviation; ESWT: endurance
shuttle walk test; ISWT: incremental shuttle walk test; MRC:
Medical Research Council dyspnoea scale.
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537.4 (378.3) seconds (p < 0.001) at graduation,
which represents a change of 341.6 (347.3) seconds
(5 minutes and 41 seconds) for the group.
Anchor-based and distribution-based MID
The relationship between anchors was established
using the Spearman’s correlations to confirm which
anchors could be used for further analysis. Anchors
for the ISWT and the CRQ-dyspnoea change were
correlated with the change in ESWT (time). Correla-
tions were 0.468 (p < 0.01) for the ISWT change
response and 0.143 (p < 0.01) for CRQ-dyspnoea. The
CRQ-dyspnoea was therefore subsequently excluded
from any further analysis.
The distribution of data using the MCID anchor for
change in ISWT was ‘less than 50 metres’ in 42.9%
(n ¼ 228) and ‘more than 50 metres’ in 57.1% (n ¼
303). The mean change (95% CI) for the ESWT were
183.7 (146.9–220.4) and 461.1 (422.1–500.1) sec-
onds, respectively, according to the ISWT change
response anchor. Figure 1 shows the absolute mean
changes for each category following the programme
completion, which were statistically significantly dif-
ferent (p < 0.001).
The distribution of responses in the global rating of
change method was ‘large improvement’ in 30.9%
(n ¼ 164), ‘moderate improvement’ in 40.1% (n ¼
213), ‘slight improvement’ in 17.3% (n ¼ 92), ‘no
change’ in 7.5% (n ¼ 40) and ‘slight deterioration’
in 4.1% (n ¼ 22). There were no significant differ-
ences between ‘moderate improvement’ and ‘slight
improvement’ (p ¼ 0.324), or between ‘no change’
and ‘slight deterioration’ (p ¼ 0.833). Therefore,
these were condensed to form new categories: ‘no
change’ (n¼ 62), ‘slight improvement’ (n¼ 305) and
‘large improvement’ (n ¼ 164). The mean change
(95% CI) for the ESWT based on the global rating
of change was 73.9 (31.7–116.0), 279.2 (244.9–
313.5) and 560.1 (505.3–614.9) seconds for response
categories ‘no change’, ‘slight improvement’ and
‘large improvement’, respectively. The differences
between all categories were statistically significant
(p < 0.001).
The ROC curve analyses was performed using the
ISWT anchor change (‘50 or more meters’) and global
rating of change (slight improvement category) that
showed a meaningful correlation with the ESWT
change (r ¼ 0.468 and r ¼ 0.464 respectively; p <
0.01) with AUC 0.773 and 0.396, respectively. There-
fore, the global rating of change was further excluded
from ROC analyses (AUC < 0.7). The ISWT change
anchor ‘50 or more meters’ was associated with a
change of 207 seconds (0.702 sensitivity and 0.699
specificity).
The 0.5  SD method yielded an MID value of
173.7 seconds.
Agreement between all methods
To enable the analysis of agreement between the dif-
ferent methods used, participants were divided into
non-responder and responder categories within each
change variable – ISWT change response anchor (‘50
or more metres’), global rating of change (slight and
large improvements were merged together as respon-
ders) and 0.5  SD.
There was poor agreement (k < 0.2) between the
suggested MID derived from different approaches
(global rating of change, distribution-based and
anchor-based methods).
Discussion
To our knowledge, this is the largest study to report an
MID of the ESWT, and the volume of data pre- and
post-rehabilitation exceeds all of the studies included
in the ERS statement about field walking tests.3
In our study, we have explored the MID using sev-
eral different approaches. Each approach yielded a
slightly different result. This disparity of outcome has
previously been documented3 in relation to the
6MWT. It is therefore perhaps unsurprising that there
is a lack of agreement for the proposed MID. The
global rating of change method tends to yield a higher
value, and of course is the approach that aligns most
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Figure 1. The means for the ESWT time change following
6-week pulmonary rehabilitation in COPD from the pres-
ent study. ESWT: endurance shuttle walk test; COPD:
chronic obstructive pulmonary disease.
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closely with the definition of a minimum clinically
important difference being ‘the smallest difference
in score in the domain of interest which patients per-
ceive as beneficial’.5 The anchor-based methods
assume that the change in outcomes are correlated;
however, it is consistently documented in the litera-
ture that these alternative outcomes reflect different
constructs and it is recognized that these are not con-
sistently related.28 It is plausible that there would be a
lack of a convincing relationship between changes in
health-related quality of life and exercise perfor-
mance. Similarly, the two exercise tests, that is, incre-
mental and endurance have fundamentally different
properties, and again, you could anticipate that their
response to rehabilitation would not necessarily be
associated.
Previous literature suggests that the MID for the
ESWT, following PR for individuals with COPD and
chronic respiratory failure is 186–199 seconds when
using the anchor-based method and 144 seconds when
using the distribution-based approach.16 Pepin et al.15
also suggested an MID of 180 seconds following PR
using only a distribution-based estimation (0.5 SD),
as weak correlations between anchors precluded an
anchor-based analysis. These values are similar to our
current study analysis establishing an MID of around
3 minutes derived from the 0.5  SD and ROC anal-
yses method (173.7 and 207.0 seconds). Interestingly,
participants in our study who did not improve their
ISWT by 50 or more metres did still improve in
ESWT by 183 seconds (‘three minutes’) currently
recognized as the MID for this test. However, the
correlation between ISWT change and ESWT time
change in our study was 0.464 (p < 0.01), which is
acceptable for the anchor analysis (r > 0.3, p < 0.05),
but we do not feel very confident to draw any conclu-
sions from it as the correlation is not greater than
0.5.13 Given the different constructs of these tests, it
would be conceivable that individuals have the capac-
ity to improve their endurance capacity despite no
meaningful change in the ISWT.
The value determined from the global rating of
change analysis was considerably greater than from the
other methods. This is consistent with the literature
where these techniques have been compared previ-
ously.11 The improvement necessary is 279 seconds
for a ‘slight improvement’ using the global rating of
change technique. We therefore are presented with
diverging results ranging from 3 minutes to approxi-
mately 4.5 minutes. This is a consequence of different
approaches. In the European Respiratory Society/
American Thoracic Society statement, the majority of
papers included in the analysis were based upon distri-
bution techniques; therefore, in line with this approach,
we can confirm that the MID is at least 174 seconds
(95% CI 139–198 seconds). The applicability of this
value to other interventions, for example, bronchodila-
tion and surgery needs to be confirmed. Currently, the
value is only relevant to exercise-based interventions
over a 6-week course of PR.
There was no relationship between ESWT walking
speed and ESWT change (r ¼ 0.089, p ¼ 0.049),
which suggests that participants walking at a higher
speed can still improve in ESWT to a similar degree
as less fit participants, and therefore our suggested
MID can be used across the whole spectrum of indi-
viduals regardless of their baseline fitness level. This
is a reflection of the fact that the selected walking
speed is relative rather than absolute.
A potential limitation could be our decision of mer-
ging categories within the global rating of change.
Participants scoring themselves with ‘slight’ or ‘mod-
erate improvement’ (92 and 213 participants respec-
tively) had very similar outcomes (p ¼ 0.324) with a
significantly overlapping CIs where the difference in
means of ESWT change between these two categories
was 37 seconds (253 and 290 seconds respectively).
Therefore, we merged these two categories even
though one can argue it does not truly reflect the one’s
perception of a slight improvement. Another reason
for this was that it increased the power of the study,
which would otherwise be underpowered due to low
number of participants classed as ‘no change’. Parti-
cipants reporting themselves as ‘no change’ and
‘slight deterioration’ (n ¼ 40 and n ¼ 22, respec-
tively; p ¼ 0.833) were merged to form new ‘no
change’ category.
Furthermore, we are presenting results of the MID
change for ESWT only as a time reference (in sec-
onds), because we believe that the ESWT change in
distance has different meanings when related to the
different walking speeds. If a distance MID is
required, it should be looked into separately for each
speed level of the ESWT. Also, it is debatable
whether to look into the ESWT change expressed as
percentage of change. It is possible that individuals
(usually those with low ISWT) may terminate ESWT
due to symptom limitation throughout the actual
warm-up part of the test, which determines their base-
line ESWT value as 0 seconds or 0 metres. In such a
case, it is subsequently difficult to determine a per-
centage change following the intervention.
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Conclusion
This is the largest study to propose MID values for the
ESWT in individuals with COPD following 6-weeks
of PR. We suggest an MID of between 174 and 279
seconds, which is derived from combining a
distribution-based and anchor-based method (global
rating of change).
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